High-resolution Melting Analysis Market Size, Analysis 2032
High-resolution Melting Analysis Market Size, Analysis 2032
Segments - High-resolution Melting Analysis Market by Product (Reagents, Instruments, Software, and Services), Application (Mutation Scanning, Microbial Species Identification, Zygosity Testing, Epigenetics, and Others), End-use (Academic Research, Clinical Diagnostics, Pharmaceutical & Biotechnology Companies, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
Upcoming
| Report ID :HC-6509
| 4.9 Rating
| 97 Reviews
| 273 Pages
| Format :
Report Description
High-resolution Melting Analysis Market
The global high-resolution melting analysis market size was USD 305.5 Million in 2023 and is projected to reach USD 345 Billion by 2032, expanding at a CAGR of 2.9% during 2024–2032. The market growth is attributed to the increasing prevalence of infectious diseases and genetic disorders and the rising investments from both public and private healthcare sectors in genomic fields.
High-resolution melting analysis (HRMA) is a molecular biology technique used for the detection of mutations, polymorphisms, and epigenetic differences in nucleic acid sequences. It is particularly crucial in genotyping, pathogen detection, and mutation scanning in the fields of medical diagnostics, research, and pharmaceuticals. The rising incidence of genetic disorders and infectious diseases is expected to propel the market during the projection period.
-
According to the World Health Organization's 2021 data, approximately 50,000 individuals die every day from communicable diseases. Moreover, the emergence of 30 new diseases over the past two decades posed a substantial threat to the well-being of millions. This escalating global burden of infectious diseases propels the market.
Regulatory approvals and clearances play a significant role in the adoption of HRMA technology in clinical diagnostics. Rising efforts to obtain regulatory approvals for HRMA-based assays and instruments contribute to market growth by increasing confidence among healthcare providers and regulatory agencies.
Impact of AI on the High-resolution Melting Analysis Market
The emergence of artificial intelligence technologies is revolutionizing the market by enhancing the accuracy of HRMA data and improving the detection of genetic variations. Machine learning algorithms learn from large datasets to identify patterns, optimize parameters, and classify samples, thereby enhancing the sensitivity of HRMA. AI technologies enable integration with large-scale genomic databases, facilitating the interpretation of HRMA with the existence of genetic knowledge. Integration of AI in HRMA systems provides valuable insights into the functional significance of detected genetic variations and potential implications for disease risk and treatment.
High-resolution Melting Analysis Market Dynamics
Major Drivers
Growing demand for automated HRMA platforms that streamline workflow, reduce time, and improve throughput drives the market. Integrating HRMA platforms with laboratory information management systems (LIMS) and other laboratory automation solutions enhances data management and analysis efficiency. Moreover, the technological advancements in HRMA technology led to the development of instruments with improved sensitivity, and resolution capabilities. This includes advancements in fluorescence detection, thermal cycling precision, and data analysis algorithms, enabling accurate and reliable results.
The need for accurate and efficient diagnostic instruments, due to the growing incidence of chronic conditions such as cancer, cardiovascular diseases, and infectious ailments, further propels the market. However, HRMA tools are particularly favored for diagnostic purposes due to their exceptional sensitivity in detecting subtle genetic alterations.
Existing Restraints
Costs and complexities associated with implementing sophisticated molecular diagnostic technologies limit the widespread adoption of high-resolution melting analysis (HRMA). While HRMA offers exceptional precision and efficiency, its deployment in clinical and research settings requires specialized instrumentation and expertise. Moreover, the complexity involved in analyzing HRMA data poses a significant barrier, necessitating the involvement of skilled professionals in molecular biology and genetic disease diagnostic. Obtaining adequately trained personnel for routine diagnostic or research processes leads to increased overall integration costs.
Emerging Opportunities
Rising demand for point-of-care testing solutions that enable rapid and decentralized genetic analysis creates lucrative opportunities in the market. This, in turn, boosts the development of portable and user-friendly HRMA devices for use in clinics, hospitals, and remote settings. HRMA technology has the potential to revolutionize point-of-care diagnostics by enabling rapid and accurate detection of infectious diseases, pharmacogenetic testing, and prenatal diagnostics. This leads to early treatment, improved patient outcomes, and enhanced healthcare decision-making.
The rising preference for personalized medicine boosts the demand for genetic testing. However, HRMA offers a versatile platform for detecting genetic variations associated with diseases, such as cancer, infectious diseases, and genetic disorders.
Scope of the High-resolution Melting Analysis Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
|
Attributes |
Details |
|
Report Title |
High-resolution Melting Analysis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2023 |
|
Historic Data |
2017 -2022 |
|
Forecast Period |
2024–2032 |
|
Segmentation |
Product (Reagents, Instruments, Software, and Services), Application (Mutation Scanning, Microbial Species Identification, Zygosity Testing, Epigenetics, and Others), and End-use (Academic Research, Clinical Diagnostics, Pharmaceutical and Biotechnology Companies, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Agilent Technologies Inc; Bioneer Corporation; Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; GenScript Biotech Corporation; Meridian Bioscience, Inc; Qiagen N.V; Quidel Corporation; Roche Diagnostics International Ltd; Thermo Fisher Scientific Inc; |
Regional Outlook
In terms of region, the high-resolution melting analysis market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
North America held a large share of the global market in 2023, owing to its well-established healthcare infrastructure, advancements in genetic research technology, and a high prevalence of genetic disorders. The region's strong emphasis on personalized medicine and genomics research has bolstered demand for high-resolution melting analysis (HRMA) technologies, contributing significantly to market growth. Additionally, government initiatives aimed at supporting genetic research and the presence of key market players have further fueled the market in this region.
The market in Asia Pacific is anticipated to register a substantial growth rate during the forecast period. This growth is attributed to factors such as the growing population, rising focus on precision medicine, escalating healthcare expenditures, and increasing investments in genetic research and development activities. Furthermore, the high prevalence of genetic disorders and rising awareness about personalized medicine are driving the adoption of HRMA technologies, thereby boosting the market in the region.
High-resolution Melting Analysis Market Segment Analysis
Product Analysis
Based on product, the high-resolution melting analysis market is divided into reagents, instruments, software, and services.
The reagents segment is expected to register a considerable CAGR in the coming years, due to the increasing adoption of molecular diagnostics and personalized medicine. Reagents are essential components in HRMA, enabling efficient and accurate detection of genetic variations. The quality and performance of reagents directly impact the reliability and reproducibility of HRMA results, making it critical for successful genetic analysis in research, clinical diagnostics, and other applications. Reagents are specifically designed to enable the amplification and visualization of nucleic acid sequences, which are essential steps in the HRMA procedure.
The software segment is projected to hold a large market share during the assessment period. The increasing need for data analysis and interpretation in research and diagnostic settings is driving the demand for HRMA software. These software solutions offer a range of functionalities, including real-time data analysis, visualization, and interpretation. Furthermore, the availability of advanced HRMA software featuring capabilities such as machine learning and artificial intelligence is fueling the segment.
Application Analysis
Based on application, the high-resolution melting analysis market is segregated into mutation scanning, microbial species identification, zygosity testing, epigenetics, and others.
The mutation scanning segment held a major share of the market in 2023, as it detects genetic variations, such as single nucleotide polymorphisms, insertions, deletions, and others. Mutation scanning is crucial in genetic research, clinical diagnostics, and pharmaceutical development for identifying genetic changes associated with diseases, drug response, and treatment resistance.
The microbial species identification segment is anticipated to expand at a significant growth rate during the forecast period. HRMA enables rapid and accurate identification of microbial species based on their nucleic acid sequences. This is crucial in microbiology research, infectious disease diagnostics, environmental monitoring, and food safety testing. HRMA differentiates between various species, strains, or variants for disease surveillance and outbreak investigation by analyzing the genetic signatures of microorganisms.
End-use Analysis
Based on end-use, the high-resolution melting analysis market is fragmented into academic research, clinical diagnostics, pharmaceutical and biotechnology companies, and others.
The clinical diagnostics segment held a key share of the market in 2023 and is expected to register a considerable CAGR in the coming years, due to the increasing number of clinical trials. HRMA technology is employed for the detection of genetic variations associated with human diseases. Clinical laboratories and healthcare institutions utilize HRMA for disease diagnosis, mutation analysis, and personalized medicine applications. Clinical laboratories greatly benefit from the effectiveness of HRM technology in delivering precise and real-time genetic information for the benefit of patients.
The academic research segment is projected to hold a large market share during the assessment period. Researchers in universities and academic laboratories utilize HRMA for a wide range of applications, including genetic analysis, epigenetic research, mutation detection, drug discovery, and microbiology. HRMA enables academics to investigate fundamental biological processes and disease mechanisms and develop novel therapeutics.
Segments
The high-resolution melting analysis market has been segmented on the basis of
Product
- Reagents
- Instruments
- Software
- Services
Application
- Mutation Scanning
- Microbial Species Identification
- Zygosity Testing
- Epigenetics
- Others
End-use
- Academic Research
- Clinical Diagnostics
- Pharmaceutical and Biotechnology Companies
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Agilent Technologies Inc
- Bioneer Corporation
- Bio-Rad Laboratories Inc
- F. Hoffmann-La Roche Ltd
- GenScript Biotech Corporation
- Meridian Bioscience, Inc
- Qiagen N.V
- Quidel Corporation
- Roche Diagnostics International Ltd
- Thermo Fisher Scientific Inc
Competitive Landscape
Key players competing in the global high-resolution melting analysis market are Agilent Technologies Inc; Bioneer Corporation; Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; GenScript Biotech Corporation; Meridian Bioscience, Inc; Qiagen N.V; Quidel Corporation; Roche Diagnostics International Ltd; and Thermo Fisher Scientific Inc.These players utilize several development strategies, including product launches, partnerships, acquisitions, and geographical expansion, to increase their global presence. For instance,
-
In June 2021, Qiagen N.V. unveiled the QIAseq FastSelect-96 RNA HRM Kit, leveraging HRM technology for RNA analysis.
-
In February 2021, GenScript Biotech Corporation introduced the GenCRISPR HRM PCR kit designed for genotyping and mutation analysis.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. High-resolution Melting Analysis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. High-resolution Melting Analysis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. High-resolution Melting Analysis Market - Supply Chain
4.5. Global High-resolution Melting Analysis Market Forecast
4.5.1. High-resolution Melting Analysis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. High-resolution Melting Analysis Market Size (000’ Units) and Y-o-Y Growth
4.5.3. High-resolution Melting Analysis Market Absolute $ Opportunity
5. Global High-resolution Melting Analysis Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. High-resolution Melting Analysis Market Size and Volume Forecast by Applications
5.3.1. Mutation Scanning
5.3.2. Microbial Species Identification
5.3.3. Zygosity Testing
5.3.4. Epigenetics
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global High-resolution Melting Analysis Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. High-resolution Melting Analysis Market Size and Volume Forecast by End Users
6.3.1. Academic Research
6.3.2. Clinical Diagnostics
6.3.3. Pharmaceutical and Biotechnology Companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global High-resolution Melting Analysis Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. High-resolution Melting Analysis Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global High-resolution Melting Analysis Demand Share Forecast, 2019-2026
8. North America High-resolution Melting Analysis Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America High-resolution Melting Analysis Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America High-resolution Melting Analysis Market Size and Volume Forecast by Applications
8.4.1. Mutation Scanning
8.4.2. Microbial Species Identification
8.4.3. Zygosity Testing
8.4.4. Epigenetics
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America High-resolution Melting Analysis Market Size and Volume Forecast by End Users
8.7.1. Academic Research
8.7.2. Clinical Diagnostics
8.7.3. Pharmaceutical and Biotechnology Companies
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America High-resolution Melting Analysis Demand Share Forecast, 2019-2026
9. Latin America High-resolution Melting Analysis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America High-resolution Melting Analysis Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America High-resolution Melting Analysis Market Size and Volume Forecast by Applications
9.4.1. Mutation Scanning
9.4.2. Microbial Species Identification
9.4.3. Zygosity Testing
9.4.4. Epigenetics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America High-resolution Melting Analysis Market Size and Volume Forecast by End Users
9.7.1. Academic Research
9.7.2. Clinical Diagnostics
9.7.3. Pharmaceutical and Biotechnology Companies
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America High-resolution Melting Analysis Demand Share Forecast, 2019-2026
10. Europe High-resolution Melting Analysis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe High-resolution Melting Analysis Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe High-resolution Melting Analysis Market Size and Volume Forecast by Applications
10.4.1. Mutation Scanning
10.4.2. Microbial Species Identification
10.4.3. Zygosity Testing
10.4.4. Epigenetics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe High-resolution Melting Analysis Market Size and Volume Forecast by End Users
10.7.1. Academic Research
10.7.2. Clinical Diagnostics
10.7.3. Pharmaceutical and Biotechnology Companies
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe High-resolution Melting Analysis Demand Share Forecast, 2019-2026
11. Asia Pacific High-resolution Melting Analysis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific High-resolution Melting Analysis Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific High-resolution Melting Analysis Market Size and Volume Forecast by Applications
11.4.1. Mutation Scanning
11.4.2. Microbial Species Identification
11.4.3. Zygosity Testing
11.4.4. Epigenetics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific High-resolution Melting Analysis Market Size and Volume Forecast by End Users
11.7.1. Academic Research
11.7.2. Clinical Diagnostics
11.7.3. Pharmaceutical and Biotechnology Companies
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific High-resolution Melting Analysis Demand Share Forecast, 2019-2026
12. Middle East & Africa High-resolution Melting Analysis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa High-resolution Melting Analysis Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa High-resolution Melting Analysis Market Size and Volume Forecast by Applications
12.4.1. Mutation Scanning
12.4.2. Microbial Species Identification
12.4.3. Zygosity Testing
12.4.4. Epigenetics
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa High-resolution Melting Analysis Market Size and Volume Forecast by End Users
12.7.1. Academic Research
12.7.2. Clinical Diagnostics
12.7.3. Pharmaceutical and Biotechnology Companies
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa High-resolution Melting Analysis Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global High-resolution Melting Analysis Market: Market Share Analysis
13.2. High-resolution Melting Analysis Distributors and Customers
13.3. High-resolution Melting Analysis Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Agilent Technologies Inc
13.4.2. Bioneer Corporation
13.4.3. Bio-Rad Laboratories Inc
13.4.4. F. Hoffmann-La Roche Ltd
13.4.5. GenScript Biotech Corporation
13.4.6. Meridian Bioscience, Inc
13.4.7. Qiagen N.V
13.4.8. Quidel Corporation
13.4.9. Roche Diagnostics International Ltd
13.4.10. Thermo Fisher Scientific Inc
Methodology
Related Reports
Some other reports from this category!
Our Clients
